FDA Approved: LEVETIRACETAM — Original Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic version of levetiracetam from Granules Pharmaceuticals Inc. under an original ANDA (ANDA217878), expanding access to this antiepileptic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures
• Juvenile Myoclonic Epilepsy
• Myoclonic Seizures
• Partial-onset Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)